Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

2012-2013 influenza update: hitting a rapidly moving target.

Jin XW, Mossad SB.

Cleve Clin J Med. 2012 Nov;79(11):777-84. doi: 10.3949/ccjm.79a.12151.

PMID:
23125327
2.

[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].

Ferraris O, Escuret V, Bouscambert-Duchamp M, Lina B, Morfin F.

Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19. Review. French.

PMID:
20303677
3.

Pandemic influenza vaccines and neuraminidase inhibitors: efficacy and side effects.

Bijl D.

Int J Risk Saf Med. 2011;23(2):65-71. doi: 10.3233/JRS-2011-0521. Review.

PMID:
21673413
4.

Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.

Nguyen HT, Fry AM, Gubareva LV.

Antivir Ther. 2012;17(1 Pt B):159-73. doi: 10.3851/IMP2067. Epub 2012 Feb 3. Review.

PMID:
22311680
5.

Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.

Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R.

Adv Ther. 2011 Nov;28(11):927-59. doi: 10.1007/s12325-011-0072-7. Epub 2011 Nov 1. Review.

PMID:
22057727
6.

The potential for multidrug-resistant influenza.

van der Vries E, Schutten M, Boucher CA.

Curr Opin Infect Dis. 2011 Dec;24(6):599-604. doi: 10.1097/QCO.0b013e32834cfb43. Review.

PMID:
22001947
7.

Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic.

López-Medrano F, Fariñas MC, Payeras A, Pachón J.

Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:49-53. doi: 10.1016/S0213-005X(12)70105-2. Review.

PMID:
23116793
8.

Current research on drugs and vaccines for fighting bird flu.

Wiwanitkit V.

Trans R Soc Trop Med Hyg. 2007 Dec;101(12):1171-2. Epub 2007 Jul 25. Review.

PMID:
17655895
9.

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.

Renaud C, Kuypers J, Englund JA.

J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. Review.

PMID:
21684202
10.

The 2009 influenza pandemic: promising lessons for antiviral therapy for future outbreaks.

Bavagnoli L, Maga G.

Curr Med Chem. 2011;18(35):5466-75. Review.

PMID:
22087838
11.

Antivirals in the management of an influenza pandemic.

Harrod ME, Emery S, Dwyer DE.

Med J Aust. 2006 Nov 20;185(10 Suppl):S58-61. Review.

PMID:
17115954
12.

Influenza: evolving strategies in treatment and prevention.

Lynch JP 3rd, Walsh EE.

Semin Respir Crit Care Med. 2007 Apr;28(2):144-58. Review.

PMID:
17458769
13.

Influenza: lessons from past pandemics, warnings from current incidents.

Horimoto T, Kawaoka Y.

Nat Rev Microbiol. 2005 Aug;3(8):591-600. Review.

PMID:
16064053
14.

Neuraminidase inhibitors and their role in avian and pandemic influenza.

Crusat M, de Jong MD.

Antivir Ther. 2007;12(4 Pt B):593-602. Review.

PMID:
17944267
16.

Influenza drug resistance.

Pizzorno A, Abed Y, Boivin G.

Semin Respir Crit Care Med. 2011 Aug;32(4):409-22. doi: 10.1055/s-0031-1283281. Epub 2011 Aug 19. Review.

PMID:
21858746
17.

Passive immune neutralization strategies for prevention and control of influenza A infections.

Ye J, Shao H, Perez DR.

Immunotherapy. 2012 Feb;4(2):175-86. doi: 10.2217/imt.11.167. Review.

18.

Planning for the next pandemic of influenza.

Gust ID, Hampson AW, Lavanchy D.

Rev Med Virol. 2001 Jan-Feb;11(1):59-70. Review.

PMID:
11241802
19.

Influenza update 2007-2008: vaccine advances, pandemic preparation.

Mossad SB.

Cleve Clin J Med. 2007 Dec;74(12):889-94. Review.

PMID:
18183839
20.

[Neuraminidase inhibitor for treatment of influenza A and B].

Wutzler P.

Internist (Berl). 2000 Feb;41(2 Pt 2):223-9. Review. German. No abstract available.

PMID:
10756440

Supplemental Content

Support Center